LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A Profit Margin

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A posts a profit margin of -0.9% as of June 2026. That compares with -2.88% in the prior-year period — up 68.9% year over year. That is below the Healthcare sector average of 21.34%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's profit margin was -2.88%. The latest reading is -0.9% — a 68.9% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 21.34% is typical. LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's -0.9% is lower that level. That is roughly 104.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -0.9% as of June 2026; use YoY and peer views to separate noise from signal.

Context for LFMDP's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 21.34%), and (3) consistency with growth and profitability. This page covers the first two; LifeMD- 8.875% PRF PERPETUAL USD 25 - Ser A's other metric pages and overview cover the third.